Drug Interactions & Safety: Conference Sessions
65 sessions at 11 meetings. Pharmacokinetic/dynamic interactions, QTc, serotonin syndrome, adverse effect management, lab monitoring.
Meetings covering drug interactions & safety
| AACAP Annual Meeting 2026 | October 26–31, 2026 | 27 sessions → |
| AAAP 37th Annual Meeting and Scientific Symposium | November 12–15, 2026 | 13 sessions → |
| MGH 50th Annual Psychopharmacology Conference | October 16–18, 2026 | 5 sessions → |
| APNA 40th Annual Conference | October 28–31, 2026 | 3 sessions → |
| NPA 32nd Annual Psychopharmacology Update 2027 | February 10–13, 2027 | 2 sessions → |
| MasterPsych Psychiatry Conference 2026 | October 19–22, 2026 | 1 session → |
| NEI Fall Congress 2026 | November 5–8, 2026 | 1 session → |
| Psych Congress 2026 | September 15–19, 2026 (past) | 6 sessions → |
| Medical Psychiatry: Comprehensive Update Conference 2026 | September 17–20, 2026 (past) | 5 sessions → |
| 39th ECNP Congress | October 10–13, 2026 (past) | 1 session → |
| WCP 2026 — 26th World Congress of Psychiatry | September 23–26, 2026 (past) | 1 session → |
Top speakers on drug interactions & safety
Christopher M. Celano · Jonathan M. Meyer · Salma Malik · Andres J. Pumariega · Jeffrey Robert Strawn · Jody L. Brown · Michelle Williamson · Raman Baweja
Upcoming
MGH 50th Annual Psychopharmacology Conference
- WorkshopPharmacology 101 for Psychopharmacologists
Ticketed workshop reviewing core pharmacokinetic and pharmacodynamic principles underlying psychiatric prescribing.
- LectureCatatonia, NMS, and Serotonin Syndrome
Reviews recognition and management of catatonia, neuroleptic malignant syndrome and serotonin syndrome.
- LectureThe Risk of QTc Interval Prolongation with Psychotropics
Examines QTc prolongation risk associated with psychotropic medications.
- SessionIlluminating the Black Box: Antidepressants, Youth, and Suicide
Evening seminar re-examining the evidence behind the antidepressant black-box warning in young people.
- LectureDrug Interactions
Clinically important psychotropic drug-drug interactions and how to avoid them.
MasterPsych Psychiatry Conference 2026
- LectureTreatment-Resistant Anxiety: Augmentation & Advanced Approaches
Augmentation and next-step options when anxiety disorders fail to respond to standard treatment.
AACAP Annual Meeting 2026
- SessionMedication Maze: Navigating Comorbidities and Maladaptive Behaviors in ASD
Alice R. Mao · Olivia Hindera · Bryan H. King · Roma Vasa
Clinical perspectives session on medication approaches for children and adolescents with autism who have comorbid conditions and maladaptive behaviors.
- LectureFocus on Clinically Relevant Pharmacokinetic and Pharmacodynamic Genes
Reviews the pharmacokinetic and pharmacodynamic genes most relevant to prescribing psychotropic medications for children and adolescents.
- SessionPractical Framework for Assessing and Managing Clinically Significant Psychotropic Medication Side Effects in Children and Adolescents
Salma Malik · Raman Baweja · Jeffrey Robert Strawn · Sadiq Naveed · Conor Wilson
Offers a practical approach to recognizing and managing clinically significant side effects of psychotropic medications in youth.
- LectureNeurological Side Effects of Psychotropic Medications in Children and Adolescents: Recognition, Management, and Clinical Implications
Covers recognizing and managing neurological adverse effects of psychotropics in young patients.
- LectureSystematic Framework for Anticipating, Identifying, Assessing, and Managing Medication-Related Adverse Effects
Presents a structured framework for anticipating and managing adverse effects of psychotropic medications in youth.
See all 27 drug interactions & safety sessions at this meeting →
APNA 40th Annual Conference
- LectureMedetomidine in the Fentanyl Era: Emergence of a Veterinary Sedative as a Novel Adulterant
Deborah Salani · Beatriz Valdes · Deana Goldin
Overview of medetomidine appearing as an adulterant in the fentanyl supply, its potency, and implications for overdose management. Pharmacology-eligible.
- WorkshopEverything Benzodiazepines: A Comprehensive Update for 2026
Full update on benzodiazepine prescribing trends, safety evidence, and structured discontinuation strategies. Pharmacology-eligible.
- LectureSafe and Effective Prescribing for Patients with Substance Use Disorders: When 'no' Is Not the Answer
Guideline-informed approaches to prescribing psychiatric medications safely for patients with active substance use. Pharmacology-eligible.
NEI Fall Congress 2026
- SymposiumShould I Stay or Should I Go? Using Dopamine Receptor Blocking Agents in Pediatrics
Weighs when to start, continue, or stop dopamine receptor blocking agents in pediatric patients, including safety and monitoring considerations.
AAAP 37th Annual Meeting and Scientific Symposium
- WorkshopKratom 2.0: High-Potency Alkaloids and Emerging Clinical Syndromes
Covers high-potency kratom alkaloid products and the new clinical syndromes and management questions they raise.
- SessionAn ICD for Harm Reduction: Methadone-Associated Torsades de Pointes in a Patient With Opioid Use Disorder
Case of a man with opioid use disorder who developed torsades de pointes on methadone and other QT-prolonging exposures. Discusses withdrawal management, methadone retitration, and the decision to place a subcutaneous ICD as a harm reduction measure.
- Oral abstractWhen Prescribed Opioids Fail: Comparing Recall Patterns between Medications for Opioid Use Disorder versus Other Opioids Used for Pain
Compares product recall patterns for medications for opioid use disorder and opioids prescribed for pain.
- PosterCracking the Black Box of the Illicit Drug Supply: Clinically Relevant Insights from Drug Checking Data in San Diego
Clinical insights from drug checking data on the San Diego illicit supply.
- PosterFrom Methadone 200 mg/day to Brixadi: Successful Inpatient Transition Using Low-Dose Buprenorphine Induction for Persistent QTc Prolongation
Case of transitioning from high-dose methadone to extended-release buprenorphine due to QTc prolongation.
See all 13 drug interactions & safety sessions at this meeting →
NPA 32nd Annual Psychopharmacology Update 2027
- LectureSexual Function in Women
Assessment and management of female sexual dysfunction in psychiatric practice, including medication-related contributors.
- LecturePsychiatric Treatment of Cardiac Patients
Safe psychotropic prescribing in cardiac disease, including QTc and drug-interaction considerations.
Past meetings
39th ECNP Congress
- SessionRS – Regulatory Spotlight Session – Metabolic risks of psychiatric medications: improving clinical safety through regulatory, industry, and academic insights
Margaret Hahn · Vikas Mohan Sharma · Katarina Vucic
Academic, industry, and regulator perspectives on managing metabolic risks of psychotropic medications.
WCP 2026 — 26th World Congress of Psychiatry
- CourseCourse 01: Pharmacology in Pregnancy
Pre-congress course on prescribing psychotropics during pregnancy.
Medical Psychiatry: Comprehensive Update Conference 2026
- LecturePsychiatric Emergencies: Catatonia, NMS, Serotonin Syndrome
Recognition and treatment of the major life-threatening neuropsychiatric syndromes seen in hospitalized patients.
CatatoniaEmergency & Acute PsychiatryTardive Dyskinesia & Movement Disorders
- LectureECG Interpretation for the CL Psychiatrist
The essentials of reading electrocardiograms that consultation-liaison psychiatrists need for safe prescribing.
- LectureQTc Prolongation: Risk Stratification and Mitigation for Challenging Clinical Cases
Case-based approaches to weighing and reducing QTc-related arrhythmia risk in psychiatric prescribing.
- LectureQTc Prolongation: Overview of Medications
A survey of which psychotropic and non-psychiatric medications prolong the QT interval and by how much.
- LectureNeuropsychiatric Manifestations and Pharmacologic Considerations in HIV and Other Infectious Disorders
Psychiatric complications of HIV and other infections, including drug-drug interaction concerns.
Psych Congress 2026
- LectureDifficult Medicines: The Art and Science of Lithium Therapy
Practical deep dive on lithium's mechanisms and dosing precision, including monitoring, toxicity mitigation, adherence, and use in special populations.
- SymposiumSolving Clinical Challenges: Untangling Sleep Problems in Psychiatric Practice
Philip Gehrman · Rakesh Jain · Hara E. Oyedeji
Case-based session on sorting whether insomnia or hypersomnia reflects medication effects, primary sleep disorders, circadian disruption, or worsening psychiatric illness, and when to order sleep studies. Developed with the Sleep Research Society Foundation.
- LectureDifficult Medicines: Navigating the Complexities of Clozapine
Deep dive into clozapine for treatment-resistant schizophrenia — initiation, monitoring requirements, side-effect management, and adherence — grounded in real-world cases.
- SymposiumDifficult Medicines: Understanding the Opioid Treatment Landscape for Safe and Effective Outcomes
Elizabeth Langmore-Avila · Arwen Podesta
Compares methadone, buprenorphine, and naltrexone for opioid use disorder, covering patient selection, titration, cardiac and overdose considerations, sedative co-prescribing, and transitions between agents.
- SymposiumMind & Metabolic Matters: Practical Guidance on Prescribing GLP-1s in Psychiatry
Brittany Albright · Jonathan M. Meyer
Clinic-ready framework for GLP-1 and dual-incretin use in psychiatric patients: selection, titration, adverse-effect management, and psychiatric considerations including eating disorder risk, mood monitoring, and craving implications.
See all 6 drug interactions & safety sessions at this meeting →
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Colorado (4)
- San Diego (4)
- Chicago (3)
- Denver (3)
- Florida (3)
- Illinois (3)
- Washington (3)
- Washington, D.C. (3)
- Arizona (2)
- Atlanta (2)
- Boston (2)
- Georgia (2)
- Hawaii (2)
- Massachusetts (2)
- New York (2)
- New Zealand (2)
- Tennessee (2)
- Texas (2)
- Albuquerque (1)
- Asheville (1)
- Auckland (1)
- Austin (1)
- Baltimore (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Christchurch (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisiana (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Memphis (1)
- Montreal (1)
- Napa (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- New Orleans (1)
- Newport Beach (1)
- North Carolina (1)
- Orlando (1)
- Phoenix (1)
- Reston (1)
- Rio de Janeiro (1)
- Scottsdale (1)
- South Africa (1)
- Tampa (1)
- United Kingdom (1)
- Virginia (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry